Kathryn Hamilton
Family · Saegertown, PANPI 1073963567
Payments from drug & device makers
Across 144 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$458
- AbbVie$257
- Pfizer$248
- Lilly USA, LLC$230
- Boehringer Ingelheim$140
- E.r. Squibb & Sons, L.L.C.$123
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,577100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $458 |
| AbbVie | 15 | $257 |
| Pfizer | 14 | $248 |
| Lilly USA, LLC | 12 | $230 |
| Boehringer Ingelheim | 8 | $140 |
| E.r. Squibb & Sons, L.L.C. | 7 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $116 |
| Medtronic | 1 | $115 |
| Merck | 6 | $106 |
| Bayer | 6 | $91 |
| Astellas Pharma US Inc | 4 | $84 |
| Alkermes, Inc. | 3 | $62 |
| Currax Pharmaceuticals LLC | 4 | $60 |
| GSK | 3 | $55 |
| Abbott | 3 | $49 |
| AstraZeneca | 3 | $44 |
| Indivior Inc. | 2 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Braeburn Inc. | 2 | $34 |
| Johnson & Johnson | 2 | $33 |
| Exact Sciences | 2 | $33 |
| Mylan Specialty L.p. | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Amgen | 1 | $16 |
| Dexcom, Inc. | 1 | $14 |
| Orexo US, Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$115
How this compares
$2,577 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 118 | $107,606 |
| OzempicSemaglutide | 33 | $32,143 |
| JardianceEmpagliflozin | 29 | $28,709 |
| XareltoRivaroxaban | 21 | $28,520 |
| XifaxanRifaximin | 13 | $23,593 |
| TradjentaLinagliptin | 17 | $22,189 |
| MounjaroTirzepatide | 20 | $21,023 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 19 | $10,074 |
| EntrestoSacubitril/Valsartan | 16 | $6,614 |
| Potassium Chloride | 42 | $4,613 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 16 | $3,857 |
| Pregabalin | 41 | $3,456 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 20 | $2,568 |
| Pantoprazole Sodium | 179 | $2,546 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 62 | $2,317 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $248 | $107,606118 claims |
| Boehringer IngelheimJardiance, Tradjenta | $140 | $50,89846 claims |
| Novo NordiskOzempic | $458 | $32,14333 claims |
| Johnson & JohnsonXarelto | $33 | $28,52021 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $37 | $23,59313 claims |
| Lilly USA, LLCMounjaro, Olanzapine | $230 | $21,71536 claims |
| AbbVieSynthroid | $257 | $2,29539 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.
Other family in Saegertown
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.